Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Caribou Biosciences (CRBU) Receivables - Other (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Receivables - Other for 6 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other rose 64.42% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 64.42% year-over-year, with the annual reading at $1.9 million for FY2025, 64.42% up from the prior year.
  • Receivables - Other for Q4 2025 was $1.9 million at Caribou Biosciences, up from $1.8 million in the prior quarter.
  • The five-year high for Receivables - Other was $5.5 million in Q4 2021, with the low at $808000.0 in Q1 2025.
  • Average Receivables - Other over 5 years is $2.3 million, with a median of $1.9 million recorded in 2025.
  • The sharpest move saw Receivables - Other skyrocketed 312.88% in 2021, then crashed 59.94% in 2023.
  • Over 5 years, Receivables - Other stood at $5.5 million in 2021, then crashed by 59.6% to $2.2 million in 2022, then grew by 3.21% to $2.3 million in 2023, then crashed by 49.34% to $1.2 million in 2024, then surged by 64.42% to $1.9 million in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $1.9 million, $1.8 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.